Table 3.

Significant variations in soluble immune factors.

	Healthy	Intermediate	Vaginosis	Healthy vs Intermediate	Healthy vs Vaginosis	Intermediate vs Vaginosis
cytokines
IL1α	62 ± 16	35 ± 6	295 ± 118	0.999	0.08	0.03
IL1β	43 ± 28	16 ± 7.5	215 ± 126	0.999	0.064	0.017
IL1ra	1.3E5 ± 2.5E4	3E5 ± 4.6E4	1.5E9 ± 1E9	0.014	0.000	0.605
IL2	1.4 ± 0.44	4.3 ± 0.6	4 ± 0.9	0.000	0.020	0.999
IL3	121 ± 9	87 ± 10	97 ± 10	0.028	0.277	0.999
IL17	12 ± 1.9	5 ± 0.5	7 ± 1	0.013	0.209	0.999
IL18	108 ± 21	216 ± 135	1373 ± 593	0.999	0.000	0.001
MIF	219 ± 113	780 ± 606	2353 ± 890	0.999	0.019	0.237
LIF	22 ± 1.3	12 ± 1.5	23 ± 2.7	0.000	0.999	0.002
SCF	23 ± 3.3	12 ± 2.8	18 ± 2.9	0.021	0.999	0.207
TNFα	14 ± 1.7	14 ± 2.3	31 ± 6	0.999	0.002	0.025
TNFβ	14 ± 1.8	9 ± 0.3	10 ± 0.6	0.013	0.999	0.271
chemokynes
IL8	157 ± 26	127 ± 45	351 ± 95	0.646	0.430	0.047
MCP1	9 ± 1.6	4.6 ± 0.5	5 ± 0.5	0.003	0.061	0.999
MIG	309 ± 119	188 ± 122	488 ± 178	0.08	0.999	0.016
MIP1α	1.7 ± 0.3	1.4 ± 0.4	2 ± 0.4	0.561	0.180	0.012
RANTES	11 ± 3.7	17 ± 12	24 ± 6	0.406	0.137	0.005
growth factors
FGFβ	32 ± 3	17 ± 1.2	18 ± 1.6	0.008	0.019	0.999
GMCSF	109 ± 4.5	81 ± 6.4	75 ± 4.6	0.015	0.000	0.593

Data are shown as the mean value (pg/mL) ± standard error of mean. Comparisons between groups were performed using a non-parametric Kruskal-Wallis test. The p values are adjusted for multiple comparisons. Significant p values are highlighted in bold.